Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast
β Scribed by Gordon F. Schwartz; Jonathan E. Tannebaum; Amelia M. Jernigan; Juan P. Palazzo
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 143 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Axillary lymph node dissection for staging the axilla in breast carcinoma patients is associated with considerable morbidity, such as edema of the arm, pain, sensory disturbances, impairment of arm mobility, and shoulder stiffness. Sentinel lymph node biopsy electively removes the first lymph node,
## Abstract ## BACKGROUND The feasibility and accuracy of sentinel lymph node (SLN) biopsy after neoadjuvant chemotherapy (NAC) for patients with breast carcinoma have been investigated primarily for the situation in which the radiocolloid imaging agent is injected peritumorally. No such study has